Trial
NCT01502605
Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Astrocytoma
Intervention
5-Aminolevulinic Acid
Why stopped
PI leaving institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-05